Vir Biotechnology WKN: A2PS0P ISIN: US92764N1028 Kürzel: VIR Forum: Aktien Thema: Hauptdiskussion

Vir Biotechnology and GSK announce global expansion to Phase 3 of COMET-ICE study evaluating VIR-7831 for the treatment of COVID-19 https://investors.vir.bio/news-releases/news-release-details/vir-biotechnology-and-gsk-announce-global-expansion-phase-3 https://investors.vir.bio/node/7446/pdf

Vir Biotechnology and GSK Start Phase 2/3 Study of COVID-19 Antibody Treatment https://www.globenewswire.com/news-release/2020/08/31/2086109/0/en/Vir-Biotechnology-and-GSK-Start-Phase-2-3-Study-of-COVID-19-Antibody-Treatment.html

https://www.prnewswire.com/news-releases/harbour-biomed-signs-strategic-collaboration-agreement-with-vir-biotechnology-to-develop-novel-therapies-for-immuno-oncology-and-infectious-diseases-301116941.html Harbour BioMed Signs Strategic Collaboration Agreement with Vir Biotechnology to Develop Novel Therapies for Immuno-Oncology and Infectious Diseases

https://www.globenewswire.com/news-release/2020/08/20/2081312/0/en/Vir-Biotechnology-Presents-Data-on-VIR-2218-from-Clinical-Studies-for-the-Treatment-of-Hepatitis-B-at-the-EASL-Digital-International-Liver-Congress.html

https://www.streetinsider.com/dr/news.php?id=17228380&gfv=1

https://www.globenewswire.com/news-release/2020/07/10/2060789/0/en/Vir-Biotechnology-Appoints-Elliott-Sigal-M-D-Ph-D-to-Board-of-Directors.html

Vir Bio prices equity offering at $42 https://seekingalpha.com/news/3589334-vir-bio-prices-equity-offering-42

Vir Biotechnology Announces Proposed Public Offering of Common Stock https://www.globenewswire.com/news-release/2020/07/06/2057834/0/en/Vir-Biotechnology-Announces-Proposed-Public-Offering-of-Common-Stock.html

Vir Biotechnology - On June 15, Co & Wuxi Biologics Entered Into A Binding Letter Of Intent https://www.reuters.com/article/brief-vir-biotechnology-on-june-15-co-wu-idUSFWN2DW0HJ

https://www.genengnews.com/covid-19-candidates/vir-biotechnology-biogen-and-niaid-with-wuxi-biologics-and-xencor

https://uk.mobile.reuters.com/article/amp/idUKASA00PRE

https://www.genengnews.com/topics/bioprocessing/returning-to-work-biotech-companies-in-china-rev-up-to-supply-critical-products-amid-covid-19-pandemic/

Leute ihr solltet in dieser angespannten Situation unbedingt einen Blick auf LAKELAND INDUSTRIES (www.lakeland.com) werfen. Dieses Unternehmen liefert in der momentanen Corona-Krise mitunter das Wichtigste. Hochwertige Ganzkörperschutzanzüge für Krankenhauspersonal. Viele Statements wurden bereits veröffentlicht dass Lakeland auf Hochtouren produziert um dem exponentiell gestiegenen Bedarf zu entsprechen. Es liegen zudem bereits viele Kaufempfehlungen für die Aktie vor. Die Aktie selbst ist in der momentanen Situation auch klar unterbewertet bietet also den perfekten Zeitpunkt um einzusteigen.